Use Cases
By Use Case
Product Launches & Market Entry
Funding Announcements
Franchise & Location Launches
Crisis Response & Reputation
Partnerships & Award Wins
Personal Brand & Leadership
Content & Campaign Amplification
Recruitment & Employer Branding
By Stages
Startups & SMBs
Solopreneurs & Creators
Agencies
Resellers
Enterprise
Pricing
Resources
Resources
Blog
Insights
Success Stories
News
Contact Us
Login
Get Started
Home
Use Cases
By Use Case
Product Launches & Market Entry
Funding Announcements
Franchise & Location Launches
Crisis Response & Reputation
Partnerships & Award Wins
Personal Brand & Leadership
Content & Campaign Amplification
Recruitment & Employer Branding
By Stages
Startups & SMBs
Solopreneurs & Creators
Agencies
Resellers
Enterprise
About Us
Privacy Policy
Terms Of Service
Editorial Content Guidelines
Contact Us
Frequently Asked Questions
Login
Login
All Categories
Business
Entertainment
Health
Finance
Other
Category
Pharmaceuticals and Biotech
Press Release
Nov 11, 2022
Genomes.io Wins the Deloitte Tech Fast 50 Challenge Award
Read More
Press Release
Oct 28, 2022
Pro-ficiency Launches New Solution: Pro-Active Protocol
Read More
Press Release
Oct 25, 2022
Becker Microbial Products Acquired by Founders of Proventus Bioscience
Innovative biotech company founders acquire another industry powerhouse.
Read More
Press Release
Oct 24, 2022
Genomes Partners With CariGenetics to Launch a Decentralized Lab for Breast Cancer Research
Read More
Press Release
Oct 13, 2022
Form Bio Doubles Down on Growth Strategy; Hires Top Industry Exec to Fuel Sales and Customer Acquisition
Mark Swendsen Appointed Chief Revenue Officer, Further Strengthening Veteran Leadership Team
Read More
Press Release
Oct 6, 2022
L-Nutra Reports Fasting-Mimicking Diet Cycles Reduce Cognitive Decline and Pathology in Alzheimer's Disease Models
Read More
Press Release
Oct 5, 2022
FDA Grants Clearance for Groundbreaking Bed Barrier
Soteria® Bed Barrier Helps Protect Against Mattress Soiling
Read More
Press Release
Oct 3, 2022
Enalare Therapeutics Receives Orphan Drug Designation From the U.S. FDA on ENA-001 for the Treatment of Apnea of Prematurity (AoP)
ENA-001, a New Chemical Entity (NCE) with a novel mechanism of action as an agnostic respiratory stimulant, has previously been granted Rare Pediatric Disease designation for the Treatment of AoP by the FDA, with eligibility for a priority review voucher (PRV). The compound is also being developed by Enalare for the treatment of post-operative respiratory depression and community drug overdose.
Read More
Press Release
Sep 27, 2022
Enalare Therapeutics Receives an Additional Award Worth Up to $50 Million From BARDA, Expanding Its Partnership in Development of ENA-001
The Funding Will Accelerate Development of an Intramuscular Formulation of ENA-001, a Novel Agnostic Respiratory Stimulant, for the Potential Treatment of Community Drug Overdose and as a Medical Countermeasure for Mass Casualty Events. The Funding Supports Development of an Intramuscular ENA-001 From Pre-Clinical Toxicology Through Filing for Approval in the United States
Read More
Press Release
Sep 27, 2022
Advent Announces Corporate Name Change to Advaxia
Read More
Press Release
Sep 26, 2022
Cambridge Isotope Laboratories, Inc. (CIL) Partners With ISOtopic Solutions to Release the New Stable Isotope-Labeled and Unlabeled Crude Lipid Yeast Extracts
Read More
Press Release
Sep 26, 2022
Sitero Announces Expanded Leadership Team
Sitero has expanded its leadership team to support the expected rapid growth of its business.
Read More
Press Release
Sep 21, 2022
Scailyte Closes Series A Funding With a CHF 6 Million Investment to Develop Strategic Partnerships in Immuno-Oncology
Read More
Press Release
Sep 21, 2022
Bron Kisler to Facilitate Collaborative Genomics Standards Workshop
The Collaborative Genomics Standards Workshop hosted by GA4GH will be facilitated by Bron Kisler (Nurocor) and Lindsay Smith (GA4GH)
Read More
Press Release
Sep 19, 2022
Core Service Group, Inc. Merges With Lifecycle Compliance, LLC
Together the two companies will expand their reach and capabilities to better serve the Pharma and Biotech Industries
Read More
Press Release
Sep 15, 2022
ApiLabs, R&D Sister Company to ApiJect, Launches Its Field Research Network
Read More
Press Release
Sep 12, 2022
FDA Registered 'World's First' Body-Mounted OLED Phototherapy Patch of Sewon E&C in Korea
Sewon E&C completes FDA registration of ultra-thin flexible OLED phototherapy patch
Read More
Press Release
Sep 8, 2022
Longwood Fund Announces Longwood Healthcare Leaders, a Webconference for Industry Leaders, on Sept. 21-22, 2022
Read More
Press Release
Sep 7, 2022
Neovii and Fosun Pharma Enter Into an Exclusive Agreement
Neovii and Fosun Pharma Enter into an Exclusive Agreement for Development and Commercialization for Grafalon in China
Read More
Press Release
Sep 7, 2022
BioLingus to Develop a Sublingual Vaccine for COVID in Cooperation With the Korean CHA Vaccine Institute and PanGen Biotech
Development of a sublingual COVID-19 subunit vaccine: the potential for a better protective efficacy and improved thermal stability during distribution and storage as compared to conventional COVID-19 vaccines
Read More
Press Release
Aug 30, 2022
Leadgene Utilizes LEADSPHERE™ Lyophilization Technology to Make Reagents Stable for Long-Term Logistics
Read More
Press Release
Aug 24, 2022
ReachBio and abc biopply Partner to Intensify Support for De-Risking Pharma's Drug Development Process
Seattle-based primary cell biology CRO ReachBio and Swiss biotech abc biopply announced today a partnership to jointly co-market their preclinical test models. The two companies plan to support their clients with an even more predictive assay portfolio to further increase the efficiency of their drug discovery and development process.
Read More
Press Release
Aug 16, 2022
With 3Brain AG's Accura-3D microchip, a first-in-class cell-electronic interface enters the market
In collaboration with Swiss precision manufacturer CSEM, 3Brain AG has announced an exciting 3D microchip for their brain-on-chip portfolio. This first-in-class cell-electronic interface technology will allow scientists to study the complexity of 3D cellular networks at unrivalled scale and precision - and to gain novel mechanistic insights into the inner workings of the most complex structure in the universe: the human brain.
Read More
Press Release
Aug 15, 2022
Cambridge Isotope Laboratories Appoints John Bakke as Vice President of Finance
Read More
Press Release
Aug 10, 2022
MyFreePharmacy Offers Relief From Prescription Drug Costs Currently Rising at 3X Inflation of Other Goods
Read More
Press Release
Aug 5, 2022
Hyris' New T-Cell Test is Finally Available to EU Countries to Easily Map Patients' Cellular Immunity to SARS-CoV-2
After months of experimentation in partnership with some world-class schools of medicine and top-tier diagnostic providers, the much-anticipated T-Cell Test from Hyris, based on innovative qPCR technology, is finally available for the European market with a CE-IVD mark. The new Test will change the way laboratories and diagnostic providers track and monitor T-cell patients' immunity to SARS-CoV-2, leveraging the unique characteristics of the Hyris System™.
Read More
Press Release
Aug 1, 2022
The Fighting for Kaiden Foundation and rareLife Solutions Announce New Partnership in Support of oneSMAvoice.com
Read More
Press Release
Jul 22, 2022
Taucoin and Golden Ally Join Together to Launch the AQP Water™ Project
Read More
Press Release
Jul 21, 2022
Epygenix Therapeutics to Participate in RW Baird's Biotech Discovery Series
Read More
Press Release
Jul 20, 2022
Clinical Outcomes Solutions and Genesis Research Announce Innovative Partnership
Collaboration provides an industry-leading offering for Life Sciences Companies
Read More
Press Release
Jul 20, 2022
PointCross Releases eDataValidator for SDTM, ADaM, SEND, and Define.XML Conformance to Prevailing FDA, CDISC, and PMDA Rules
Integrated QC dashboard and unlimited validation cycles for interim and final datasets creates industry's most user-friendly validator
Read More
Press Release
Jul 19, 2022
Pharma Solutions Launches Suspicious Order Monitoring Product for DEA Federal Compliance
Read More
Press Release
Jul 19, 2022
RxCelerate Launch RxNfinity™: A Next-Generation Machine Learning-Enabled Small Molecule Discovery Platform
World-first as adaptive chemical space is launched as a service
Read More
Press Release
Jul 19, 2022
Dennis Wong Joins ANANDA Scientific Inc. Board of Directors
Read More
Press Release
Jul 19, 2022
Dennis Wong Joins ANANDA Scientific's Board of Directors
Read More
Press Release
Jul 12, 2022
Nilogen and Scailyte Are Joining Forces to Find the 'Right' Treatment for Every Patient
Read More
Press Release
Jul 12, 2022
Elixiron Immunotherapeutics Receives Grant From the Alzheimer's Association to Trial Microglia-Targeting Immunotherapy
Read More
Press Release
Jul 12, 2022
Selux Diagnostics Receives $8.0 Million in Additional Funding to Redefine Speed in Microbiology Laboratory Testing
Latest milestone brings the Selux Next-Generation Phenotyping (NGP) platform one step closer to impacting patient care with same-shift Antibiotic Susceptibility Testing (AST).
Read More
Press Release
Jul 6, 2022
CaaMTech Collaborates With the Alexander Shulgin Research Institute to Study Shulgin Compounds
CaaMTech will help carry on Dr. Alexander Shulgin's legacy by developing ASRI's novel compounds
Read More
Press Release
Jul 1, 2022
Enalare Therapeutics Receives a National Institutes of Health (NIH) Grant Award
Funding from the NIH's National Institute on Drug Abuse (NIDA) will Support Further Development of ENA001, an Agnostic Respiratory Stimulant
Read More
Press Release
Jun 28, 2022
Circuit Clinical and Pottstown Medical Specialists Inc. (PMSI) Bring Clinical Research to 180K+ Patients Across Greater Northwest Philadelphia Region
Patients from Montgomery, Berks, and Chester Counties will now have access to clinical trials managed by Labcorp
Read More
Press Release
Jun 24, 2022
Jeanne Hecht Joins Pro-ficiency Board of Directors
Read More
Press Release
Jun 22, 2022
Announcing the Release of MiXCR 4.0, a Powerful Tool for Immunome Profiling
Read More
Press Release
Jun 21, 2022
New Alzheimer's Treatment on Horizon as Dementia Reversed for First Time in Dogs
Australian biotech Skin2Neuron Pty Ltd (S2N) has achieved what no one has to date - reversal of a dementia-like syndrome in a natural animal form of Alzheimer's disease.
Read More
Press Release
Jun 21, 2022
Ferrer Brings ALSton the Dragon to Life to Raise Awareness of ALS
This is the new fantasy creature from the Phantasticals campaign that Ferrer has relaunched, coinciding with Global Amyotrophic Lateral Sclerosis (ALS) Awareness Day, on June 21. The aim is to raise public awareness of this rare, neurodegenerative, progressive disease that affects the motor neurons in the brain. Ferrer is leading the ADORE Phase III clinical trial to evaluate the safety and efficacy of the investigational drug FNP122 in the treatment of ALS.
Read More
Press Release
Jun 20, 2022
Bron Kisler Joins Nurocor as SVP Customer Alliances and Partnerships
Globally recognized leader in international standards development joins the leader in digitalized clinical development.
Read More
Press Release
Jun 15, 2022
A New T-Cell activation assay based on Hyris qPCR Technology marks a disruptive approach for the detection of SARS-CoV-2 specific cellular immunity
A scientific paper recently published in Nature Biotechnology reveals new research regarding how we track and monitor T-cell patients' immunity to SARS-CoV-2, leveraging the unique characteristics of Hyris System™. The study results from a joint effort of an international research team from the Icahn School of Medicine at Mount Sinai, Singapore Duke-NUS Medical School, laboratory diagnostic service providers Synlab, and Hyris.
Read More
Press Release
Jun 14, 2022
Actinogen Announces Phase 2 Trials in Alzheimer's Disease and Depression
Treatment in sight for over 25 million Americans after new clinical trial confirms safety and cognitive enhancement activity of low, once-a-day doses of Xanamem
Read More
Press Release
Jun 9, 2022
Robin Newman Joins Pro-ficiency Board of Directors
Read More
Press Release
Jun 8, 2022
Enalare Therapeutics Announces Positive Topline Results With ENA001 in a Propofol Induced Respiratory Depression Study
ENA001, an Agnostic Respiratory Stimulant, Successfully Achieved the Study Primary Endpoint and Was Shown to Be Safe and Well Tolerated
Read More
Press Release
Jun 7, 2022
AnaBios Closes Financing With Ampersand Capital Partners
Read More
Press Release
Jun 6, 2022
Qualis Innovations Inc. Becomes Fully Reporting Company
Read More
Press Release
Jun 2, 2022
Dr. Jeffrey Kasher Joins Pro-Ficiency Board of Directors
Read More
Press Release
Jun 1, 2022
JM Health Rebrands as Veranova Following Sale to Altaris Capital Partners
Read More
Press Release
May 20, 2022
University Gastroenterology Partners With Virgo Surgical Video Solutions to Reimagine IBD Clinical Trial Recruitment
Will use AI to identify and enroll the best candidates
Read More
Press Release
May 19, 2022
Recardio's Phase 2 Results Will Be Presented as Latebreaker at World Congress on Heart Failure 2022 in Madrid
Recardio Inc., a clinical-stage life science company developing regenerative therapies for cardiovascular diseases, announced that the study results of Recardio's Phase 2 clinical study in Acute Myocardial Infarction will be presented on Saturday, May 21, 2022, during the Latebreaker Session at the World Congress on Acute Heart Failure 2022 in Madrid.
Read More
Press Release
May 12, 2022
Genzada Pharmaceuticals Opens Phase 1B Metastatic Breast Cancer Trial
Read More
Press Release
May 11, 2022
Ki Young Sohn, CEO of Enzychem Lifesciences Honored by World Biz Magazine Leadership Awards With 'Top 100 Innovation CEO' Award
ENZYCHEM LIFESCIENCES' CHAIRMAN & CEO RECEIVES "TOP 100 INNOVATION CEO OF 2022 AWARD".
Read More
Press Release
May 10, 2022
InDevR Launches Highly Multiplexed Kit for Rapid Pneumococcal Vaccine Characterization
Read More
Press Release
May 9, 2022
Blue Note Therapeutics and Bixink Enter Licensing Agreement for attune™ and DreAMLand™, Prescription Digital Therapeutics for Mental Well-Being in Cancer Patients
Read More
First
Prev
10
11
12
13
14
15
Next
